# Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)

> **NCT03369743** · — · COMPLETED · sponsor: **Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida** · enrollment: 125 (actual)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03369743
- **Lead sponsor:** Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-02
- **Primary completion:** 2018-06-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03369743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03369743, "Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03369743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*